How do the post-exposure protocols differ, and which…
Infection control in the ADC exam tests decision-making around exposure incidents, instrument classification, and decontamination protocols. This exam-level vignette tests your ability to work through clinical details and arrive at the correct management.
Two dental workers sustain needlestick injuries from source patients: Worker A's source is hepatitis B positive, Worker B's source is hepatitis C positive. How do the post-exposure protocols differ, and which infection is more likely to be transmitted?
- A. Both infections are managed identically after needlestick
- B. Hepatitis B has a lower transmission risk than HIV
- C. Hepatitis B: higher transmission risk (~30% from HBeAg-positive source vs 0.3% for HIV)
- D. Hepatitis C is preventable by vaccination
The only ADC prep platform where every answer is traced to the guideline source.
No invented explanations. No guesswork content. Every question mapped to Therapeutic Guidelines, Odell's, IADT, and more — so you study what the exam actually tests.
Score high, pay less.
Think you already know your stuff? The Remy Challenge: 15 questions, one attempt — 13 timed and marked, plus 2 interactive finishers. Your score sets your discount — top scores take 50% off any plan, strong scores 30%, and every challenger leaves with at least 20%, locked for 72 hours.
Try Reviz on WhatsApp.
Message Remy and get one cited clinical question every morning — free until the day you sit. No card details, no forms, no app to download. Just open WhatsApp and start practising.
Show the answer and cited explanation
Hepatitis B: higher transmission risk (~30% from HBeAg-positive source vs 0.3% for HIV). If the worker is vaccinated and has documented immunity (anti-HBs >10 mIU/ml), no treatment is needed — the vaccine provides protection. If not immune: hepatitis B immunoglobulin (HBIG) within 72 hours PLUS accelerated vaccination course. Hepatitis C: lower transmission risk (~1.8%) but NO vaccine and NO post-exposure prophylaxis exists. Management is surveillance: HCV RNA testing at 4-6 weeks, antibody testing at 12 and 24 weeks. If seroconversion occurs, early antiviral treatment (direct-acting antivirals) achieves >95% cure rate. The key difference: HBV is preventable by vaccination, HCV is not
Exam preparation FAQ
Every answer, traced to the source.
Remy — the AI tutor inside Reviz — drills you on 7,000+ ADC-style cited questions with spaced repetition, on WhatsApp and the web.
Start with 10 free questions